Shionogi & Co., Ltd. (4507.T)
JPY 2178.5
(0.51%)
JPY 2178.5
(0.51%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 164.35 Billion JPY | -13.46% |
| 2022 | 189.92 Billion JPY | 20.73% |
| 2021 | 157.31 Billion JPY | 17.01% |
| 2020 | 134.44 Billion JPY | 25.75% |
| 2019 | 106.91 Billion JPY | 0.57% |
| 2018 | 106.31 Billion JPY | -9.64% |
| 2017 | 117.66 Billion JPY | -18.33% |
| 2016 | 144.06 Billion JPY | 14.55% |
| 2015 | 125.76 Billion JPY | 1.41% |
| 2014 | 124.01 Billion JPY | 10.34% |
| 2013 | 112.39 Billion JPY | -25.69% |
| 2012 | 151.25 Billion JPY | -13.55% |
| 2011 | 174.96 Billion JPY | -10.34% |
| 2010 | 195.14 Billion JPY | -1.83% |
| 2009 | 198.78 Billion JPY | 3.66% |
| 2008 | 191.75 Billion JPY | 168.31% |
| 2007 | 71.46 Billion JPY | -14.73% |
| 2006 | 83.81 Billion JPY | -7.13% |
| 2005 | 90.24 Billion JPY | -6.9% |
| 2004 | 96.93 Billion JPY | 15.71% |
| 2003 | 83.77 Billion JPY | -13.37% |
| 2002 | 96.7 Billion JPY | -51.54% |
| 2001 | 199.54 Billion JPY | -3.91% |
| 2000 | 207.67 Billion JPY | 12.28% |
| 1999 | 184.95 Billion JPY | 11.3% |
| 1998 | 166.17 Billion JPY | 5.99% |
| 1997 | 156.78 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 145.92 Billion JPY | -7.49% |
| 2024 Q1 | 157.74 Billion JPY | -4.02% |
| 2023 Q3 | 145.52 Billion JPY | -18.32% |
| 2023 Q1 | 171.59 Billion JPY | -9.65% |
| 2023 Q2 | 178.16 Billion JPY | 3.82% |
| 2023 FY | 164.35 Billion JPY | -13.46% |
| 2023 Q4 | 164.35 Billion JPY | 12.94% |
| 2022 Q4 | 189.92 Billion JPY | 3.73% |
| 2022 FY | 189.92 Billion JPY | 20.73% |
| 2022 Q1 | 164.44 Billion JPY | 4.53% |
| 2022 Q2 | 162.94 Billion JPY | -0.91% |
| 2022 Q3 | 183.09 Billion JPY | 12.36% |
| 2021 Q1 | 118.45 Billion JPY | -11.89% |
| 2021 FY | 157.31 Billion JPY | 17.01% |
| 2021 Q4 | 157.31 Billion JPY | 24.27% |
| 2021 Q3 | 126.58 Billion JPY | 4.14% |
| 2021 Q2 | 121.55 Billion JPY | 2.61% |
| 2020 FY | 134.44 Billion JPY | 25.75% |
| 2020 Q1 | 96.08 Billion JPY | -10.13% |
| 2020 Q3 | 95.45 Billion JPY | 1.2% |
| 2020 Q4 | 134.44 Billion JPY | 40.84% |
| 2020 Q2 | 94.33 Billion JPY | -1.82% |
| 2019 Q2 | 86.33 Billion JPY | 4.42% |
| 2019 Q1 | 82.67 Billion JPY | -22.23% |
| 2019 Q4 | 106.91 Billion JPY | 40.74% |
| 2019 FY | 106.91 Billion JPY | 0.57% |
| 2019 Q3 | 75.96 Billion JPY | -12.01% |
| 2018 FY | 106.31 Billion JPY | -9.64% |
| 2018 Q2 | 95.09 Billion JPY | -14.48% |
| 2018 Q4 | 106.31 Billion JPY | 24.82% |
| 2018 Q3 | 85.17 Billion JPY | -10.43% |
| 2018 Q1 | 111.19 Billion JPY | -5.5% |
| 2017 Q1 | 121.29 Billion JPY | -15.8% |
| 2017 FY | 117.66 Billion JPY | -18.33% |
| 2017 Q4 | 117.66 Billion JPY | 4.65% |
| 2017 Q3 | 112.42 Billion JPY | -7.66% |
| 2017 Q2 | 121.75 Billion JPY | 0.38% |
| 2016 Q3 | 128.84 Billion JPY | 15.06% |
| 2016 Q4 | 144.06 Billion JPY | 11.81% |
| 2016 Q2 | 111.98 Billion JPY | 2.77% |
| 2016 Q1 | 108.96 Billion JPY | -13.36% |
| 2016 FY | 144.06 Billion JPY | 14.55% |
| 2015 Q3 | 120.73 Billion JPY | 5.71% |
| 2015 Q1 | 118.8 Billion JPY | -4.21% |
| 2015 Q2 | 114.21 Billion JPY | -3.86% |
| 2015 Q4 | 125.76 Billion JPY | 4.16% |
| 2015 FY | 125.76 Billion JPY | 1.41% |
| 2014 Q1 | 88.19 Billion JPY | -21.53% |
| 2014 Q3 | 115.31 Billion JPY | 12.3% |
| 2014 Q2 | 102.68 Billion JPY | 16.43% |
| 2014 Q4 | 124.01 Billion JPY | 7.54% |
| 2014 FY | 124.01 Billion JPY | 10.34% |
| 2013 Q2 | 139.14 Billion JPY | -6.99% |
| 2013 FY | 112.39 Billion JPY | -25.69% |
| 2013 Q4 | 112.39 Billion JPY | -21.41% |
| 2013 Q3 | 143 Billion JPY | 2.77% |
| 2013 Q1 | 149.6 Billion JPY | -1.09% |
| 2012 Q4 | 151.25 Billion JPY | -4.84% |
| 2012 FY | 151.25 Billion JPY | -13.55% |
| 2012 Q1 | 167.88 Billion JPY | -4.04% |
| 2012 Q2 | 161.53 Billion JPY | -3.78% |
| 2012 Q3 | 158.94 Billion JPY | -1.6% |
| 2011 Q3 | 174.31 Billion JPY | -7.39% |
| 2011 Q1 | 179.97 Billion JPY | -7.77% |
| 2011 Q4 | 174.96 Billion JPY | 0.37% |
| 2011 FY | 174.96 Billion JPY | -10.34% |
| 2011 Q2 | 188.23 Billion JPY | 4.59% |
| 2010 Q2 | 190.46 Billion JPY | -7.61% |
| 2010 Q3 | 183 Billion JPY | -3.92% |
| 2010 Q4 | 195.14 Billion JPY | 6.64% |
| 2010 Q1 | 206.15 Billion JPY | 3.71% |
| 2010 FY | 195.14 Billion JPY | -1.83% |
| 2009 Q3 | 199.74 Billion JPY | 1.06% |
| 2009 FY | 198.78 Billion JPY | 3.66% |
| 2009 Q4 | 198.78 Billion JPY | -0.48% |
| 2009 Q2 | 197.66 Billion JPY | 0.0% |
| 2008 Q4 | 191.75 Billion JPY | 0.0% |
| 2008 FY | 191.75 Billion JPY | 168.31% |
| 2007 FY | 71.46 Billion JPY | -14.73% |
| 2006 FY | 83.81 Billion JPY | -7.13% |
| 2005 FY | 90.24 Billion JPY | -6.9% |
| 2004 FY | 96.93 Billion JPY | 15.71% |
| 2003 FY | 83.77 Billion JPY | -13.37% |
| 2002 FY | 96.7 Billion JPY | -51.54% |
| 2001 FY | 199.54 Billion JPY | -3.91% |
| 2000 FY | 207.67 Billion JPY | 12.28% |
| 1999 FY | 184.95 Billion JPY | 11.3% |
| 1998 FY | 166.17 Billion JPY | 5.99% |
| 1997 FY | 156.78 Billion JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 24.98 Billion JPY | -557.732% |
| Takeda Pharmaceutical Company Limited | 7834.78 Billion JPY | 97.902% |
| Sumitomo Pharma Co., Ltd. | 751.37 Billion JPY | 78.126% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.39 Billion JPY | -4741.09% |
| Nippon Shinyaku Co., Ltd. | 42.86 Billion JPY | -283.396% |
| Kaken Pharmaceutical Co., Ltd. | 27.86 Billion JPY | -489.801% |
| Eisai Co., Ltd. | 494.82 Billion JPY | 66.785% |
| Morishita Jintan Co., Ltd. | 5.04 Billion JPY | -3160.992% |
| Hisamitsu Pharmaceutical Co., Inc. | 61.69 Billion JPY | -166.402% |
| Mochida Pharmaceutical Co., Ltd. | 30.83 Billion JPY | -433.063% |
| Fuso Pharmaceutical Industries,Ltd. | 39.79 Billion JPY | -313.012% |
| Nippon Chemiphar Co., Ltd. | 31.08 Billion JPY | -428.741% |
| Tsumura & Co. | 132.88 Billion JPY | -23.68% |
| Kissei Pharmaceutical Co., Ltd. | 39.79 Billion JPY | -313.043% |
| Torii Pharmaceutical Co., Ltd. | 13.29 Billion JPY | -1136.023% |
| Towa Pharmaceutical Co., Ltd. | 274.75 Billion JPY | 40.182% |
| Fuji Pharma Co., Ltd. | 44.15 Billion JPY | -272.195% |
| Zeria Pharmaceutical Co., Ltd. | 70.7 Billion JPY | -132.451% |
| KYORIN Holdings, Inc. | 46.89 Billion JPY | -250.487% |
| Taiko Pharmaceutical Co.,Ltd. | 7 Billion JPY | -2246.908% |
| Daito Pharmaceutical Co.,Ltd. | 25.43 Billion JPY | -546.071% |
| SymBio Pharmaceuticals Limited | 8.14 Billion JPY | -1918.561% |
| MedRx Co., Ltd | 129 Million JPY | -127306.202% |
| Mizuho Medy Co.,Ltd. | 3.27 Billion JPY | -4922.223% |
| Solasia Pharma K.K. | 673 Million JPY | -24321.1% |
| Modalis Therapeutics Corporation | 645.5 Million JPY | -25361.384% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 31.38 Billion JPY | -423.737% |
| Sawai Group Holdings Co., Ltd. | 163.99 Billion JPY | -0.22% |
| Cyfuse Biomedical K.K. | 1.01 Billion JPY | -16151.112% |
| Toho Holdings Co., Ltd. | 523.98 Billion JPY | 68.634% |
| Koa Shoji Holdings Co.,Ltd. | 6.95 Billion JPY | -2264.01% |